Growth hormone dosing variables in growth hormone-deficient adults

David M. Cook, Kevin C.J. Yuen

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


The use of growth hormone (GH) replacement for GH-deficient adults is now in its 10th year of FDA-approved use in the United States; it has been used for a longer period of time in some European countries. Despite widespread experience, there is still lack of consensus regarding the best approach to GH initiation and titration in adults with growth hormone deficiency. Several factors must be considered prior to dose selection, including patient age, gender, symptoms, and the use and route of estrogen replacement therapy. We retrospectively examined GH dosing practices within our institution over a 5-year period to define GH dose requirements during the initial titration and maintenance phases, the frequency of dose adjustments, and the reasons behind the dose adjustments in young and older adults. Based on this review, we offer practical recommendations for endocrinologists in the management of adults with hypopituitarism and long-term GH treatment.

Original languageEnglish (US)
Pages (from-to)49-54
Number of pages6
JournalGrowth Hormone and IGF Research
Issue numberSUPPL.
StatePublished - Jul 2006


  • Adult
  • Dose adjustment
  • Growth hormone deficiency
  • Safety

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology


Dive into the research topics of 'Growth hormone dosing variables in growth hormone-deficient adults'. Together they form a unique fingerprint.

Cite this